Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Poniard Pharma says picoplatin did not improve survival in late stage study; shares tumble
Yahoo/AP
Monday, November 16, 2009 - 9:59am
tags:
Poniard, drug studies, cancer, picoplatin
[video] Cholesterol Drug Battle: Merck vs. Abbott Labs
CNBC
Monday, November 16, 2009 - 9:25am
tags:
Vytorin, Niaspan, Merck, cholesterol, Abbott Laboratories, Zetia
Lilly's new development star signals strategic shift
Fierce Biotech
Monday, November 16, 2009 - 9:23am
tags:
Eli Lilly, R&D
Playing the Options Game in RIM; Cel Sci Not Yet Trading to Its Potential
Seeking Alpha
Monday, November 16, 2009 - 9:22am
tags:
options, Cel-Sci
GlaxoSmithKline could pay Nabi more than $500 million in deal to develop anti-smoking vaccines
Yahoo/AP
Monday, November 16, 2009 - 9:11am
tags:
GSK, Nabi, vaccines, partnerships, smoking cessation
Bayer, Novartis, Sanofi-Aventis Rated New ‘Buy’ at Deutsche Bank
Bloomberg
Monday, November 16, 2009 - 9:10am
tags:
upgrades, Bayer, Novartis, Sanofi
Sanofi-Aventis says flu vaccine approved in France
Marketwatch
Monday, November 16, 2009 - 9:07am
tags:
France, Sanofi, vaccines, swine flu, H1N1
Another Vytorin Mess For Merck
Forbes
Monday, November 16, 2009 - 9:06am
tags:
Merck, Zetia, Vytorin
Bristol-Myers to split off Mead Johnson
Marketwatch
Monday, November 16, 2009 - 8:49am
tags:
Bristol-Myers Squibb, Mead Johnson, reorganization
What Genentech and Roche Got From Congress for $15M
BNET Pharma
Sunday, November 15, 2009 - 6:17pm
tags:
Roche, congress, Genentech, healthcare reform
Short Blood Supply Means Long Outlook for Cerus
Seeking Alpha
Sunday, November 15, 2009 - 6:15pm
tags:
Cerus, INTERCEPT
FDA Panel to Consider New Flu Vaccine Technology
WSJ Online
Sunday, November 15, 2009 - 6:14pm
tags:
FDA, Flu, vaccines, Protein Biosciences
Big Pharma Willing to Pay for Biotech Innovation
Seeking Alpha
Sunday, November 15, 2009 - 6:11pm
tags:
Big Pharma, Regeneron, Sanofi, Abbott Laboratories, Bristol-Myers Squibb, biotech, Astellas
Vials of 5 Genzyme Drugs for Rare Diseases May Be Contaminated, F.D.A. Says
New York Times
Saturday, November 14, 2009 - 1:35pm
tags:
Genzyme
NicOx Reports Positive Data for Cholesterol Drug
Med Tech Sentinel
Saturday, November 14, 2009 - 1:34pm
tags:
NicOx
Drug may slow down Parkinson's, Alzheimer's and Huntington's diseases
virtualmedicalcentre.com
Saturday, November 14, 2009 - 1:16pm
tags:
Parkinson's Disease, Alzheimer's disease
Endo Pharma to pay US$ 23 mn to LecTec to settle patent litigation
Pharmabiz
Saturday, November 14, 2009 - 1:12pm
tags:
Endo, LecTec
Why the FDA Needs to Accept PhRMA's Social Proposal
Advertising Age
Saturday, November 14, 2009 - 1:05pm
tags:
PhRMA
Abbott: Brave or Stupid?
Motley Fool
Saturday, November 14, 2009 - 1:00pm
tags:
Abbott Laboratories
Questioning Pfizer's Integrity
Motley Fool
Saturday, November 14, 2009 - 12:58pm
tags:
Pfizer, Neurontin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.